{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:40:14Z","timestamp":1773297614531,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS113591"],"award-info":[{"award-number":["R01-NS113591"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-HD090255"],"award-info":[{"award-number":["U54-HD090255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by epilepsy, intellectual disability, and benign tumors of the brain, heart, skin, and kidney. Animal models have contributed to our understanding of normal and abnormal human brain development, but the construction of models that accurately recapitulate a human pathology remains challenging. Recent advances in stem cell biology with the derivation of human-induced pluripotent stem cells (hiPSCs) from somatic cells from patients have opened new avenues to the study of TSC. This approach combined with gene-editing tools such as CRISPR\/Cas9 offers the advantage of preserving patient-specific genetic background and the ability to generate isogenic controls by correcting a specific mutation. The patient cell line and the isogenic control can be differentiated into the cell type of interest to model various aspects of TSC. In this review, we discuss the remarkable capacity of these cells to be used as a model for TSC in two- and three-dimensional cultures, the potential variability in iPSC models, and highlight differences between findings reported to date.<\/jats:p>","DOI":"10.1186\/s13229-020-0320-2","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T14:03:22Z","timestamp":1582121002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex"],"prefix":"10.1186","volume":"11","author":[{"given":"Wardiya","family":"Afshar Saber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7044-2953","authenticated-orcid":false,"given":"Mustafa","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"issue":"1","key":"320_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615(1):125\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"320_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0072-9752(07)87009-6","volume-title":"Malformations of the Nervous System","author":"Paolo Curatolo","year":"2007","unstructured":"Curatolo P, Bombardieri R. Tuberous sclerosis. In: Handbook of clinical neurology: Elsevier; 2007. p. 129\u201351."},{"issue":"13","key":"320_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N E J Med. 2006;355(13):1345\u201356.","journal-title":"N E J Med"},{"issue":"4","key":"320_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00381-017-3335-z","volume":"33","author":"JS Katz","year":"2017","unstructured":"Katz JS, et al. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation. Childs Nerv Syst. 2017;33(4):601\u20137.","journal-title":"Childs Nerv Syst"},{"issue":"7","key":"320_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0387-7604(01)00304-7","volume":"23","author":"M Mizuguchi","year":"2001","unstructured":"Mizuguchi M, Takashima S. Neuropathology of tuberous sclerosis. Brain Dev. 2001;23(7):508\u201315.","journal-title":"Brain Dev"},{"issue":"12","key":"320_CR6","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1111\/j.1528-1167.2009.02191.x","volume":"50","author":"K Boer","year":"2009","unstructured":"Boer K, et al. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers. Epilepsia. 2009;50(12):2629\u201337.","journal-title":"Epilepsia"},{"issue":"1","key":"320_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s11689-016-9142-0","volume":"8","author":"A M\u00fchlebner","year":"2016","unstructured":"M\u00fchlebner A, et al. Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis complex (TSC): evidence from layer-specific marker expression. J Neurodev Dis. 2016;8(1):9.","journal-title":"J Neurodev Dis"},{"issue":"4","key":"320_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ana.21342","volume":"63","author":"DM Talos","year":"2008","unstructured":"Talos DM, et al. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol. 2008;63(4):454\u201365.","journal-title":"Ann Neurol"},{"issue":"1","key":"320_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1749-6632.1991.tb37747.x","volume":"615","author":"GH Watson","year":"1991","unstructured":"Watson GH. Cardiac rhabdomyomas in tuberous sclerosis. Ann N Y Acad Sci. 1991;615(1):50\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"320_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1196\/annals.1413.018","volume":"1131","author":"CG Glasgow","year":"2008","unstructured":"Glasgow CG, et al. Lymphatic involvement in lymphangioleiomyomatosis. Ann N Y Acad Sci. 2008;1131:206\u201314.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"320_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s40620-018-0547-6","volume":"32","author":"A Volpi","year":"2019","unstructured":"Volpi A, et al. Tuberous sclerosis complex: new insights into clinical and therapeutic approach. J Nephrol. 2019;32(3):355\u201363.","journal-title":"J Nephrol"},{"key":"320_CR12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2147\/TCRM.S145630","volume":"15","author":"IE Overwater","year":"2019","unstructured":"Overwater IE, et al. Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives. Ther Clin Risk Manag. 2019;15:951\u20135.","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"320_CR13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.7150\/jca.14747","volume":"7","author":"SL Habib","year":"2016","unstructured":"Habib SL, et al. Is mTOR inhibitor good enough for treatment all tumors in TSC patients? J Cancer. 2016;7(12):1621\u201331.","journal-title":"J Cancer"},{"issue":"12","key":"320_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/acn3.494","volume":"4","author":"DA Krueger","year":"2017","unstructured":"Krueger DA, et al. Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders. Ann Clin Transl Neurol. 2017;4(12):877\u201387.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"320_CR15","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","volume":"93","author":"IE Overwater","year":"2019","unstructured":"Overwater IE, et al. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology. 2019;93(2):e200\u20139.","journal-title":"Neurology"},{"key":"320_CR16","doi-asserted-by":"crossref","unstructured":"Giannikou K, et al. Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission. Genet Med. 2019.","DOI":"10.1038\/s41436-020-01066-w"},{"issue":"1","key":"320_CR17","doi-asserted-by":"publisher","first-page":"15816","DOI":"10.1038\/ncomms15816","volume":"8","author":"KR Martin","year":"2017","unstructured":"Martin KR, et al. The genomic landscape of tuberous sclerosis complex. Nat Commun. 2017;8(1):15816.","journal-title":"Nat Commun"},{"issue":"2","key":"320_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393.","journal-title":"Cell"},{"issue":"5","key":"320_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.pediatrneurol.2012.02.015","volume":"46","author":"MH Kohrman","year":"2012","unstructured":"Kohrman MH. Emerging treatments in the management of tuberous sclerosis complex. Pediatric Neurol. 2012;46(5):267\u201375.","journal-title":"Pediatric Neurol"},{"issue":"4","key":"320_CR20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"320_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20160446","volume":"214","author":"E Ercan","year":"2017","unstructured":"Ercan E, et al. Neuronal CTGF\/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex. J Exp Med. 2017;214(3):681\u201397.","journal-title":"J Exp Med"},{"issue":"1","key":"320_CR22","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske EP, et al. Tuberous sclerosis complex. Nat Rev Dis Prim. 2016;2(1):16035.","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"320_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"1","key":"320_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.stemcr.2018.11.019","volume":"12","author":"AG Nadadhur","year":"2019","unstructured":"Nadadhur AG, et al. Neuron-glia interactions increase neuronal phenotypes in tuberous sclerosis complex patient iPSC-derived models. Stem Cell Rep. 2019;12(1):42\u201356.","journal-title":"Stem Cell Rep"},{"issue":"11","key":"320_CR25","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41380-018-0018-4","volume":"23","author":"M Sundberg","year":"2018","unstructured":"Sundberg M, et al. Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin. Mol Psychiatr. 2018;23(11):2167\u201383.","journal-title":"Mol Psychiatr"},{"issue":"47","key":"320_CR26","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1523\/JNEUROSCI.0642-19.2019","volume":"39","author":"KD Winden","year":"2019","unstructured":"Winden KD, et al. Biallelic mutations in TSC2 lead to abnormalities associated with cortical tubers in human iPSC-derived neurons. J Neurosci. 2019;39(47):9294\u2013305.","journal-title":"J Neurosci"},{"issue":"4","key":"320_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.stemcr.2017.02.020","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, et al. Abnormal neural progenitor cells differentiated from induced pluripotent stem cells partially mimicked development of TSC2 neurological abnormalities. Stem Cell Rep. 2017;8(4):883\u201393.","journal-title":"Stem Cell Rep"},{"key":"320_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mcn.2018.08.004","volume":"92","author":"AJ Zucco","year":"2018","unstructured":"Zucco AJ, et al. Neural progenitors derived from tuberous sclerosis complex patients exhibit attenuated PI3K\/AKT signaling and delayed neuronal differentiation. Mol Cell Neurosci. 2018;92:149\u201363.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"320_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.celrep.2016.02.090","volume":"15","author":"V Costa","year":"2016","unstructured":"Costa V, et al. mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis. Cell Reports. 2016;15(1):86\u201395.","journal-title":"Cell Reports"},{"issue":"10","key":"320_CR30","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41591-018-0139-y","volume":"24","author":"JD Blair","year":"2018","unstructured":"Blair JD, Hockemeyer D, Bateup HS. Genetically engineered human cortical spheroid models of tuberous sclerosis. Nat Med. 2018;24(10):1568\u201378.","journal-title":"Nat Med"},{"key":"320_CR31","doi-asserted-by":"publisher","first-page":"5B.7.1","DOI":"10.1002\/cpsc.46","volume":"44","author":"JC Giacalone","year":"2018","unstructured":"Giacalone JC, et al. CRISPR-Cas9-based genome editing of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol. 2018;44:5B.7.1\u20135B.7.22.","journal-title":"Curr Protoc Stem Cell Biol"},{"issue":"3","key":"320_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers SM, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009;27(3):275\u201380.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"320_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78(5):785\u201398.","journal-title":"Neuron"},{"issue":"4","key":"320_CR34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.celrep.2016.09.054","volume":"17","author":"D Ebrahimi-Fakhari","year":"2016","unstructured":"Ebrahimi-Fakhari D, et al. Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex. Cell Rep. 2016;17(4):1053\u201370.","journal-title":"Cell Rep"},{"issue":"1","key":"320_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13073-016-0347-3","volume":"8","author":"N Grabole","year":"2016","unstructured":"Grabole N, et al. Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model. Genome Med. 2016;8(1):94.","journal-title":"Genome Med"},{"issue":"7413","key":"320_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nature11310","volume":"488","author":"PT Tsai","year":"2012","unstructured":"Tsai PT, et al. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature. 2012;488(7413):647\u201351.","journal-title":"Nature"},{"issue":"12","key":"320_CR37","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/s41593-017-0004-1","volume":"20","author":"CJ Stoodley","year":"2017","unstructured":"Stoodley CJ, et al. Altered cerebellar connectivity in autism and cerebellar-mediated rescue of autism-related behaviors in mice. Nat Neurosci. 2017;20(12):1744\u201351.","journal-title":"Nat Neurosci"},{"issue":"2","key":"320_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.celrep.2018.09.039","volume":"25","author":"PT Tsai","year":"2018","unstructured":"Tsai PT, et al. Sensitive periods for cerebellar-mediated autistic-like behaviors. Cell Rep. 2018;25(2):357\u2013367.e4.","journal-title":"Cell Rep"},{"issue":"50","key":"320_CR39","doi-asserted-by":"publisher","first-page":"20284","DOI":"10.1073\/pnas.1315710110","volume":"110","author":"T Kadoshima","year":"2013","unstructured":"Kadoshima T, et al. Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex. Proc Natl Acad Sci U S A. 2013;110(50):20284\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"320_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pa\u015fca","year":"2015","unstructured":"Pa\u015fca AM, et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods. 2015;12(7):671\u20138.","journal-title":"Nat Methods"},{"issue":"4","key":"320_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.stem.2016.12.007","volume":"20","author":"M Bershteyn","year":"2017","unstructured":"Bershteyn M, et al. Human iPSC-derived cerebral organoids model cellular features of lissencephaly and reveal prolonged mitosis of outer radial glia. Cell Stem Cell. 2017;20(4):435\u2013449.e4.","journal-title":"Cell Stem Cell"},{"key":"320_CR42","doi-asserted-by":"crossref","unstructured":"Blair JD, Bateup HS. New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids. Developmental Dynamics. 2019.","DOI":"10.1002\/dvdy.60"},{"issue":"16","key":"320_CR43","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1007\/s00018-012-1196-x","volume":"70","author":"L Magri","year":"2013","unstructured":"Magri L, Galli R. mTOR signaling in neural stem cells: from basic biology to disease. Cell Mol Life Sci. 2013;70(16):2887\u201398.","journal-title":"Cell Mol Life Sci"},{"issue":"20","key":"320_CR44","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-17-0925","volume":"77","author":"LM Julian","year":"2017","unstructured":"Julian LM, et al. Human pluripotent stem cell-derived TSC2-haploinsufficient smooth muscle cells recapitulate features of lymphangioleiomyomatosis. Cancer Res. 2017;77(20):5491\u2013502.","journal-title":"Cancer Res"},{"issue":"1","key":"320_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1513\/pats.200705-061VS","volume":"5","author":"VP Krymskaya","year":"2008","unstructured":"Krymskaya VP. Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis. Proc Am Thorac Soc. 2008;5(1):119\u201326.","journal-title":"Proc Am Thorac Soc"},{"key":"320_CR46","unstructured":"Delaney SP, et al. Stem cell models identify lineage-specific catabolic signaling, neoplastic mechanisms and therapeutic vulnerabilities in tuberous sclerosis. bioRxiv. 2019:683359."},{"issue":"10","key":"320_CR47","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2208::AID-CNCR21>3.0.CO;2-K","volume":"83","author":"T Al-Saleem","year":"1998","unstructured":"Al-Saleem T, et al. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer. 1998;83(10):2208\u201316.","journal-title":"Cancer"},{"issue":"4","key":"320_CR48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/gcc.2870130411","volume":"13","author":"EP Henske","year":"1995","unstructured":"Henske EP, et al. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band l6p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer. 1995;13(4):295\u20138.","journal-title":"Genes Chromosomes Cancer"},{"issue":"9366","key":"320_CR49","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","volume":"361","author":"N El-Hashemite","year":"2003","unstructured":"El-Hashemite N, et al. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet. 2003;361(9366):1348\u20139.","journal-title":"Lancet"},{"issue":"1","key":"320_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/lrb.2009.0020","volume":"8","author":"J Yu","year":"2010","unstructured":"Yu J, Henske EP. mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \u201cperfect storm\u201d of pro-metastatic factors in LAM pathogenesis. Lymphat Res Biol. 2010;8(1):43\u20139.","journal-title":"Lymphat Res Biol"},{"issue":"4","key":"320_CR51","doi-asserted-by":"publisher","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","volume":"286","author":"J Yu","year":"2004","unstructured":"Yu J, et al. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am J Physiol Lung Cell Mol Physiol. 2004;286(4):L694\u2013700.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"320_CR52","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ajpath.2013.05.024","volume":"183","author":"WK Steagall","year":"2013","unstructured":"Steagall WK, et al. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. Am J Pathol. 2013;183(3):938\u201350.","journal-title":"Am J Pathol"},{"key":"320_CR53","first-page":"19","volume":"1","author":"C Li","year":"2016","unstructured":"Li C, et al. Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis. JCI Insight. 2016;1:19.","journal-title":"JCI Insight"},{"issue":"6","key":"320_CR54","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.2353\/ajpath.2009.080799","volume":"174","author":"E Lesma","year":"2009","unstructured":"Lesma E, et al. The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells. Am J Pathol. 2009;174(6):2150\u20139.","journal-title":"Am J Pathol"},{"issue":"4","key":"320_CR55","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0002-9440(10)61198-4","volume":"167","author":"E Lesma","year":"2005","unstructured":"Lesma E, et al. Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor. Am J Pathol. 2005;167(4):1093\u2013103.","journal-title":"Am J Pathol"},{"key":"320_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2016.03.015","volume":"60","author":"M Sahin","year":"2016","unstructured":"Sahin M, et al. Advances and future directions for tuberous sclerosis complex research: recommendations from the 2015 strategic planning conference. Pediatric Neurol. 2016;60:1\u201312.","journal-title":"Pediatric Neurol"},{"issue":"6","key":"320_CR57","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.stemcr.2018.04.020","volume":"10","author":"E Kiskinis","year":"2018","unstructured":"Kiskinis E, et al. All-optical electrophysiology for high-throughput functional characterization of a human iPSC-derived motor neuron model of ALS. Stem Cell Rep. 2018;10(6):1991\u20132004.","journal-title":"Stem Cell Rep"},{"key":"320_CR58","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fnins.2018.00451","volume":"12","author":"W Afshar Saber","year":"2018","unstructured":"Afshar Saber W, et al. All-optical assay to study biological neural networks. Front Neurosci. 2018;12:451.","journal-title":"Front Neurosci"},{"issue":"21","key":"320_CR59","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1091\/mbc.e17-03-0209","volume":"28","author":"B Roberts","year":"2017","unstructured":"Roberts B, et al. Systematic gene tagging using CRISPR\/Cas9 in human stem cells to illuminate cell organization. Mol Biol Cell. 2017;28(21):2854\u201374.","journal-title":"Mol Biol Cell"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-020-0320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13229-020-0320-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-020-0320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T06:35:06Z","timestamp":1613802906000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularautism.biomedcentral.com\/articles\/10.1186\/s13229-020-0320-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1186\/s13229-020-0320-2","relation":{},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"30 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mustafa Sahin has received research funding from Roche, Novartis, Pfizer, LAM Therapeutics, and Quadrant Biosciences and has served on the Scientific Advisory Board of Sage Therapeutics, Roche, Takeda, and PTEN Research Foundation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}